These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7402892)

  • 21. [Diuretics and vascular risk factors. Comparison between tienilic acid and chlorothiazide (author's transl)].
    Andrejak M; Makdassi R; de Frémont JF; Kassouf J; Tolani M; Fievet P; Fournier A
    Nephrologie; 1981; 2(3):96-101. PubMed ID: 7301035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.
    Robin MA; Maratrat M; Le Roy M; Le Breton FP; Bonierbale E; Dansette P; Ballet F; Mansuy D; Pessayre D
    J Clin Invest; 1996 Sep; 98(6):1471-80. PubMed ID: 8823314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune mechanisms in tienilic acid associated hepatotoxicity.
    Neuberger J; Williams R
    Gut; 1989 Apr; 30(4):515-9. PubMed ID: 2714684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver cell surface expression of the antigen reacting with liver-kidney microsomal antibody (LKM).
    Lenzi M; Bianchi FB; Cassani F; Pisi E
    Clin Exp Immunol; 1984 Jan; 55(1):36-40. PubMed ID: 6692597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic disorders associated with liver-kidney microsomal antibodies.
    Smith MG; Williams R; Walker G; Rizzetto M; Doniach D
    Br Med J; 1974 Apr; 2(5910):80-4. PubMed ID: 4596402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ticrynafen recalled.
    FDA Drug Bull; 1980 Feb; 10(1):3-4. PubMed ID: 7358240
    [No Abstract]   [Full Text] [Related]  

  • 27. HBsAg-induced hypertrophic smooth endoplasmic reticulum as a target for liver-kidney microsomal (LKM) antibodies.
    Ballardini G; Landi P; Busachi CA; Bianchi FB; Pisi E
    Clin Exp Immunol; 1981 Mar; 43(3):599-604. PubMed ID: 7026097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute interstitial nephritis in a patient taking tienilic acid.
    Walker RG; Whitworth JA; Kincaid-Smith P
    Br Med J; 1980 May; 280(6225):1212. PubMed ID: 7388469
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of human hepatitis anti-liver kidney microsomes (LKM2) autoantibodies on rat liver sections is predominantly due to reactivity with rat liver P-450 IIC11.
    Pons C; Dansette PM; Amar C; Jaouen M; Wolf CR; Gregeois J; Homberg JC; Mansuy D
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1328-34. PubMed ID: 1762080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum.
    Alvarez F; Bernard O; Homberg JC; Kreibich G
    J Exp Med; 1985 May; 161(5):1231-6. PubMed ID: 3989471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of tienilic acid.
    Beg MA; Ragland R
    Postgrad Med J; 1979; 55 Suppl 3():127-32. PubMed ID: 388398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ticrynafen-associated hepatic injury: analysis of 340 cases.
    Zimmerman HJ; Lewis JH; Ishak KG; Maddrey WC
    Hepatology; 1984; 4(2):315-23. PubMed ID: 6706306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute uratic nephropathy caused by tienilic acid].
    Semplicini A; Pessina AC; Palatini P; Casiglia E; Hlede M; Rossi GP
    G Clin Med; 1981 Jul; 62(7):495-500. PubMed ID: 7308633
    [No Abstract]   [Full Text] [Related]  

  • 34. Diuretics, hyperuricaemia, and tienilic acid.
    Lancet; 1980 Sep; 2(8196):681-2. PubMed ID: 6106790
    [No Abstract]   [Full Text] [Related]  

  • 35. Fulminant hepatitis due to tienilic acid.
    Biour M; Poujol A; Chazouilleres O; Housset C; Giral P; Poupon R
    Lancet; 1991 Oct; 338(8771):891. PubMed ID: 1681248
    [No Abstract]   [Full Text] [Related]  

  • 36. Total ban on tienilic acid.
    Simpson FO; Waal-Manning HJ
    Lancet; 1980 May; 1(8175):978-9. PubMed ID: 6103314
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterization of the microsomal antigen related to a subclass of active chronic hepatitis.
    Rizzetto M; Bianchi FB; Doniach D
    Immunology; 1974 Mar; 26(3):589-601. PubMed ID: 4604207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic hepatitis: interest of a classification based on the presence or the absence of HBs Ag, smooth muscle antibody and microsomal antibody (author's transl)].
    Poupon R; Petit J; Bodin F; de Saint-Maur PP; Homberg JC; Darnis F
    Gastroenterol Clin Biol; 1980 Oct; 4(10):666-73. PubMed ID: 7439610
    [No Abstract]   [Full Text] [Related]  

  • 39. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.
    Manns MP; Johnson EF; Griffin KJ; Tan EM; Sullivan KF
    J Clin Invest; 1989 Mar; 83(3):1066-72. PubMed ID: 2466049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute renal failure associated with ticrynafen.
    Paddack GL; Wahl RC; Holman RE; Schorr WJ; Lacher JW
    JAMA; 1980 Feb 22-29; 243(8):764-5. PubMed ID: 7351818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.